Skip to content

David P. Schenkein, MD

NPI 1144330176ActiveIndividual· Internal Medicine· Boston, MA

Internal Medicine (MD) in Boston, Massachusetts, licensed in MA, with an NPI issued in August 2006. Regeneron Pharmaceuticals, Inc. was the largest of 5 companies reporting payments in 2025, $920,430 in all, mostly consulting fees.

Overview

NPI1144330176
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 31, 2006
Last updated in NPPESFeb 22, 2010

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X54139MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$920,430 · 62 payments from 5 companies
  • 2024$829,812 · 47 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Consulting Fee$890,238 · 16 payments
  • Travel and Lodging$26,753 · 14 payments
  • Food and Beverage$3,439 · 32 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Boston

All Internal Medicine providers in Massachusetts →